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Equine P2 protein has been isolated from horse spinal cord
and its structure determined to 2.1 A˚. Since equine myelin is a
viable alternative to bovine tissue for large-scale preparations,
characterization of the proteins from equine spinal cord
myelin has been initiated. There is an unusually high amount
of P2 protein in equine CNS myelin compared with other
species. The structure was determined by molecular replace-
ment and subsequently refined to an R value of 0.187 (Rfree =
0.233). The structure contains a molecule of the detergent
LDAO and HEPES buffer in the binding cavity and is
otherwise analogous to other cellular retinol-binding proteins.
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1. Introduction
In our laboratory, equine tissue has replaced well character-
ized bovine tissue. Since most of our research involves spinal
cord, there is an inherent risk of contracting variant Creutz-
feldt–Jakob disease (the human form of bovine spongiform
encephalopathy, BSE) if we were to continue using bovine
tissue. As BSE presents problems in several countries, an
alternate source of spinal cord is desirable: equine tissue
provides the necessary amount for bulk experiments. Up until
now very little if any work has been performed to characterize
horse myelin. Although the myelin proteins are largely
conserved across species, our initial investigations have shown
that although similar to other well defined myelin proteins
(e.g. bovine, human, rat, murine), equine myelin has some
distinct differences. For example, our initial investigations into
the major component of basic protein (Wood et al., 2002)
shows a higher molecular weight of 18766 compared with
18501 and 18635 for human and bovine, respectively, owing to
the increased number of amino acids in the equine protein:
172 compared with 170 for human and 169 for bovine. While
careful isolation of the MBP isoforms by CM52 cation-
exchange chromatography shows the same panoply of charged
isoforms, there was one unexpected result: the large amount of
P2 protein present in equine CNS tissue.
Myelin P2 protein is normally found as a small (14.8 kDa)
component of the peripheral nervous system (PNS), making
up some 2–15% of the total PNS protein (Kadlubowski et al.,
1984). It is very probably localized to the cytoplasmic face of
the Schwann cell membrane (Weize & Brostoff, 1985), where
it associates with the membrane. Its exact function is unclear,
although it is obvious from experimental evidence (Uyemura
et al., 1984) and its relation to other hydrophobic ligand-
binding proteins that this function involves the binding of
lipophiles, thereby suggesting a role in lipid transport and
storage in myelinating Schwann cells (Uyemura et al., 1984).
(The paradox, however, is that most of the major lipids found
in myelin, e.g. cholesterol and phosphatidylcholine, are very
much larger than the binding pocket in P2 and hence its role
may be to shuttle the lipid components.)
In common with many myelin proteins, injection of purified
P2 protein (Kadlubowski & Hughes, 1979) or neuritogenic
peptides derived from it (Uyemura et al., 1982) into experi-
mental animals results in an experimental allergic neuritis
(EAN). In the case of P2, an animal model for Guillain–Barre´
syndrome, a demyelinating disease of human PNS, is
produced. Interestingly, in horses there is a condition known
as neuritis of the cauda equina (NCE), which leads to paralysis
of the tail, bladder and rectum. Although the aetiology of the
condition is unknown, the paralysis of the trigeminal and facial
nerves show similarities to Guillain–Barre´ syndrome in man
and experimental allergic neuritis (EAN) in animals (Kadlu-
bowski & Ingram, 1981; Greenwood et al., 1973).
On the basis of both sequence and three-dimensional
structure, myelin P2 protein is closely related to cellular
lipophilic transport proteins such as cellular retinol-binding
proteins (CRBP, CRBP II; Bashor et al., 1973; Li et al., 1986),
heart fatty-acid-binding protein (Heuckeroth et al., 1987),
intestinal fatty-acid-binding protein (Sacchettini et al., 1988)
and the cellular retinoic acid-binding proteins (CRABP,
CRABP II; Sundelin et al., 1985; Bailey & Siu, 1988; Kitamoto
et al., 1988). The structures of several of these proteins are
known, including that of bovine myelin P2 protein (Jones et al.,
1988; Cowan et al., 1993), all of which show the same ten-
stranded antiparallel -barrel closed at one end by a helix–
turn–helix motif in the large loop between strands 1 and 2 of
the barrel. The other inter-strand loops are short. The serum
retinol-binding protein family (serum RBP, -lactoglobulin
etc.) differs from the above, having an eight-stranded anti-
parallel -barrel with N- and C-terminal extensions.
In this paper, we describe the purification and structure
determination of P2 protein from horse central nervous
system (CNS) tissue to high resolution. We routinely extract
P2 from our detergent-solubilized fractions of MBP and PLP
and, as an added experiment, decided to keep the solubilizing
detergent LDAO (lauryl dimethylamine-N-oxide) present at
its CMC (0.1%) throughout the purification and crystallization
protocol, almost treating it like a membrane protein in many
respects (although it is not), just to see if the copious lipid
present would be incorporated into the active site or liganded
to the exterior surface of the protein. P2 can also be easily
extracted from equine CNS tissue by simply using buffer and
200 mM NaCl and gently agitating by homogenizing or gentle
sonication. Visual inspection of the remaining solution by
SDS–PAGE indicates that P2 extraction is almost complete.
Since there is a relatively large amount of P2 in equine myelin
(between 5 and 10% of the total myelin proteins), this initial
pre-solubilization is a useful clean-up step prior to removal of
MBP and PLP proteins.
2. Materials and methods
All materials used in the purification were of reagent grade or
higher. Lauryl dimethylamine-N-oxide (LDAO) was from
Fluka, Dorset, England. Cation-exchange chromatography
used Whatman CM52 cellulose and Superdex 75 (Amersham
Bioscience, UK) was used for gel filtration.
2.1. Purification of P2 protein
Myelin was purified from horse spinal cord by the method
of Norton & Poduslo (1973). P2 protein was extracted from
myelin using a low concentration of the detergent LDAO and
purified by chromatography on CM52 cellulose. Briefly,
myelin was suspended at2 mg ml1 protein in 10 mM PIPES
pH 6.8, 5 mM EDTA, 200 mM KCl, 0.1%(v/v) LDAO by
gentle stirring. The suspension was sonicated for 2 min (bath
sonicator) and then stirred gently for 20 min. Following
centrifugation (16 000 rev min1, 20 min, 277 K) to separate
the extract, the residue was re-extracted a further three times.
The soluble extracts were pooled and dialysed overnight
against 10 mM Tricine pH 8.9, 1 mM EDTA, 0.1%(v/v) LDAO
and centrifuged [18 000 rev min1, 30 min, 277 K] to remove
precipitated lipid and contaminating cyclic nucleotide
30-phosphatase (CNPase). The clarified extract was concen-
trated (Amicon Ultrafiltration, YM10 membrane from Milli-
pore UK Ltd) and applied onto a 1  20 cm column of CM 52
cellulose equilibrated with 10 mM PIPES pH 6.8, 1 mM
EDTA, 0.1% LDAO. After washing, the bound proteins,
including P2, were eluted with a linear 0–0.5M gradient of
1M NaCl in equilibration buffer. Fractions containing P2, as
judged by SDS–PAGE, were pooled, concentrated to 1 ml
and applied onto a Superdex 75 (1.6  50 cm column) in the
above equilibration buffer to remove minor contaminants.
The S-75 eluate was concentrated, typically to 5 mg ml1
protein, and stored at 253 K.
Pure P2 protein was subject to electrospray mass spectro-
metry following inline HPLC to remove buffer components.
From the deconvoluted ion series, the major sample compo-
nent gave a weight of 14 761 Da.
2.2. Crystallization, data collection, structure solution and
refinement
Purified P2 protein formed crystals in several of the
Hampton Research A screen solutions. Crystals grown using
sitting-drop vapour diffusion in optimized condition No. 41
(0.1M HEPES pH 5.6, 20% PEG 4000, 15% 2-propanol)
diffracted well. Data were collected to better than 2.1 A˚ at
stations 9.6 and 14.1 at SRS, Daresbury on a crystal form with
space group P3221 and unit-cell parameters a = b = 45.9,
c = 125.8 A˚,  = 120 at 100 K using 10% glycerol as cryo-
protectant. Data were reduced using DENZO/SCALEPACK
(Otwinowski &Minor, 1997); subsequent data processing used
the CCP4 suite. Interestingly, we frequently obtained drops in
which two crystal forms had grown simultaneously: the form
used in this analysis, shaped like thick prisms, and also fine
long needle-shaped crystals. Synchrotron data were collected
from several of these needle-shaped crystals, but they only
diffracted to about 4.5 A˚ in monoclinic space group C2.
The structure was solved by molecular replacement using
AMoRe (Navaza, 1994). P2 bovine myelin protein stripped of
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water molecules (PDB code 1pmp) was used as the initial
search molecule. Before refinement, 5% of the observed
reflections were flagged for calculation of the free R factor,
Rfree. The structure was initially refined using REFMAC
(Murshudov et al., 1997) and the P2 structure was manually
built into the resulting electron-density
map using QUANTA. As no sequence
is available for equine P2, the assign-
ment of amino acids was based on
sequence alignment of four other
myelin P2 sequences (Fig. 2). Side
chains were added when electron
density permitted. Several iterative
rounds of model building and refine-
ment allowed over 95% of the protein
model to be built. Subsequent rounds of
model building and refinement (again
using REFMAC) involved TLS and
restrained refinement (Winn et al.,
2001). The final model contains 1016
protein atoms, 102 water molecules, a
HEPES molecule and a detergent
LDAO molecule. The final R factor is
0.187 and Rfree is 0.233. Table 1 outlines
the refinement parameters. (space
group P3221 was confirmed over the
symorphic P3121 by initial trial refine-
ments in each space group).
3. Results and discussion
The overall structure is homologous to
other P2 and CRBP structures deter-
mined to date, comprising a single
domain consisting of a ten-stranded up-
and-down -barrel with two orthogonal
-sheets. The top sheet consists of
strands 1–4 and the bottom sheet of
strands 5–10; strand 1 is shared by both
sheets, with a classic -bulge (Chan et
al., 1993) seen at residue 11. The centre
of the barrel is closed at one end by two
short -helices. Residues Met119 and
Trp97 and a salt bridge between OD1
and OD2 on Asp76 and NE and NH2
on Arg78 on neighbouring loops also
close the opening. The entrance at the
other end of the barrel is restricted by a
number of conserved hydrophobic
residues pointing into the barrel. These
include Ser1, Lys44, Ile49, Leu66 and
Leu91. Access to the interior of the
barrel is gained by a small orifice
formed between the second helix and
the second hairpin turn involving Thr29,
Leu32, Phe57 and Lys58. The opening is
controlled by the conformation of
Phe57 (Cowan et al., 1993). Fig. 1 illustrates the similarity in
secondary-structure topology by overlaying the current
equine structure (dark blue) with three other CRBP structures
(rat, green, PDB code 1crb; bovine, orange, 1pmp; human,
purple, 1cbq). The equine, rat and bovine structures have a
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Figure 1
Stereo overlay of equine (dark blue), rat (green), bovine (orange) and human (purple) P2
structures.
Figure 2
Sequence alignment of equine, bovine, rabbit, human and mouse myelin P2 proteins.
Figure 3
View of binding pocket with HEPES and LDAO.
near-identical match, with the human structure showing slight
deviations in the loop between -strands 5 and 6 (at the open
end of the barrel) and the small loop between strands 8 and 9.
There are two significant mutations in equine P2 when
compared with other myelin P2 sequences (Fig. 2): Arg88 and
Lys120 are both mutated to Ala. This would deplete the
overall positive charge on the molecule by 2 when compared
with other myelin P2s. A lack of density in these regions
suggested other assignments to be inappropriate. In several
cellular retinol-binding proteins (CRBPs), Arg88 is replaced
with a glycine. Since there is no sequence information for
equine P2, the side-chain assignments were made solely from
electron-density modelling, taking cognisance of sequence
information from other species. The electron density for the
structure was very good and these different side-chain resi-
dues were only confirmed after careful refinement. Other
minor mutations were Val for Ile48 and Ala for Thr80 and
Ser90. Fig. 2 shows the sequence alignment of equine, bovine,
rabbit, human and mouse myelin P2, illustrating the high
degree of conservation between species. Electrospray mass
spectrometry gave a mass of 14761, while the calculated mass
from the sequence gives 14288. However, when the contri-
bution from the HEPES and LDAO molecules that are found
in the cavity is added in, this brings the weight to 14756 Da,
which gives further confidence to the assigned residues.
3.1. Binding site and ligands
Two molecules have been found in the binding site: the
detergent LDAO and HEPES buffer, both sequestered from
the crystallization conditions (Fig. 3). The HEPES buffer
molecule is at the hydrophilic end of the compartment. Each
of the O atoms on the sulfonyl head group makes contact with
different moieties: O(1) to water 61, O(2) to Cys117 and O(3)
to the oxygen at the head of the detergent, LDAO. Interest-
ingly, the hydroxyl group of the buffer points inwardly rather
than in an extended conformation to allow favourable
contacts with Ser55 OG and the carbonyl O atom of Lys58.
With the close proximity of the adjacent hydrophobic region
of LDAO this O—H rotation makes sense. There are nine
water molecules that appear to form a halo-type motif around
the HEPES group. The positioning of a number of water
molecules (usually between five and nine) at this end of the
barrel seems to be a common feature of P2 and CRBP
structures.
The tail of the detergent makes favourable hydrophobic
interactions with the residues present in the opening at the
second hairpin turn, while the head group makes interactions
with HEPES O(3) and a number of water molecules in the
‘halo’. There is also a hydrophobic interaction (3.78 A˚)
between C(8) of HEPES and C(4) of LDAO. The above
arrangement is not dissimilar to that found in the insect fatty-
acid-binding protein isolated fromManduca sexta (Benning et
al., 1992), where a sulfate ion derived from crystallization in
ammonium sulfate is also seen at the hydrophilic end of the
barrel along with the fatty acid, palmitic acid. Initially, we tried
to model a retinol molecule into this site since the aromatic
ring was clearly defined in the initial density. However, there
was no connective density from this proposed head group to
the unsaturated chain (of the subsequent LDAO).
4. Conclusion
Structurally, equine P2 is practically identical to other P2 and
CRBP structures, even though the equine myelin was derived
from CNS rather than PNS tissue. Careful examination of the
residual density from difference maps showed no evidence of
lipid or other molecules associated with the exterior of the
protein despite careful extraction, purification and crystal-
lization under detergent conditions. This is in contrast to the
lipid-bound form of bovine P2 crystallized by Sedzik et al.
(2003). SDS–PAGE clearly shows lipid being carried forward
in our purification steps and probably into crystallization. It
may be that the second form of poorly diffracting rod-shaped
crystals does have associated lipid and hence the hetero-
geneity of the system prevents the growth of better diffracting
crystals. The presence of HEPES and LDAO molecules in the
binding pocket is not surprising since these molecules, derived
from purification and crystallization procedures, fit the
requirements of the binding pocket: a charged entity at the
hydrophilic end and a hydrophobic tail pointing towards the
opening at the second hairpin turn.
We are grateful for myelin preparation (Mr D. Kirkham,
Glasgow University, Veterinary School) and for funding
(Medical Research Council).
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